These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22023046)

  • 1. SMILES-based QSAR approaches for carcinogenicity and anticancer activity: comparison of correlation weights for identical SMILES attributes.
    Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Anticancer Agents Med Chem; 2011 Dec; 11(10):974-82. PubMed ID: 22023046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. coral Software: QSAR for Anticancer Agents.
    Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
    Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CORAL: QSPR model of water solubility based on local and global SMILES attributes.
    Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jan; 90(2):877-80. PubMed ID: 22921649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of graph invariants and attributes of simplified molecular input-line entry system (SMILES) to build up models for sweetness.
    Achary PGR; Toropova AP; Toropov AA
    Food Res Int; 2019 Aug; 122():40-46. PubMed ID: 31229093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells.
    Toropov AA; Toropova AP; Puzyn T; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jun; 92(1):31-7. PubMed ID: 23566368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quasi-SMILES: quantitative structure-activity relationships to predict anticancer activity.
    Toropova AP; Toropov AA
    Mol Divers; 2019 May; 23(2):403-412. PubMed ID: 30306392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.
    Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
    Eur J Pharm Sci; 2013 Feb; 48(3):532-41. PubMed ID: 23287365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CORAL: quantitative structure-activity relationship models for estimating toxicity of organic compounds in rats.
    Toropova AP; Toropov AA; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    J Comput Chem; 2011 Sep; 32(12):2727-33. PubMed ID: 21656789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMILES-based QSAR models for the calcium channel-antagonistic effect of 1,4-dihydropyridines.
    Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
    Arch Pharm (Weinheim); 2013 Feb; 346(2):134-9. PubMed ID: 23280520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CORAL: Binary classifications (active/inactive) for drug-induced liver injury.
    Toropova AP; Toropov AA
    Toxicol Lett; 2017 Feb; 268():51-57. PubMed ID: 28111161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR models for toxicity of organic substances to Daphnia magna built up by using the CORAL freeware.
    Toropova AP; Toropov AA; Benfenati E; Gini G
    Chem Biol Drug Des; 2012 Mar; 79(3):332-8. PubMed ID: 22136580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
    Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
    SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-QSAR in cell biology: Model of cell viability as a mathematical function of available eclectic data.
    Toropova AP; Toropov AA
    J Theor Biol; 2017 Mar; 416():113-118. PubMed ID: 28087422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculation of molecular features with apparent impact on both activity of mutagens and activity of anticancer agents.
    Toropov AA; Toropova AP; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Anticancer Agents Med Chem; 2012 Sep; 12(7):807-17. PubMed ID: 22583412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CORAL: QSAR models for carcinogenicity of organic compounds for male and female rats.
    Toropova AP; Toropov AA
    Comput Biol Chem; 2018 Feb; 72():26-32. PubMed ID: 29310001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the index of ideality of correlation to improve predictive potential for biochemical endpoints.
    Toropov AA; Toropova AP
    Toxicol Mech Methods; 2019 Jan; 29(1):43-52. PubMed ID: 30064284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity, anticancer activity and blood brain barrier: similarity and dissimilarity of molecular alerts.
    Toropov AA; Toropova AP; Benfenati E; Salmona M
    Toxicol Mech Methods; 2018 Jun; 28(5):321-327. PubMed ID: 29281931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quasi-QSAR for mutagenic potential of multi-walled carbon-nanotubes.
    Toropov AA; Toropova AP
    Chemosphere; 2015 Apr; 124():40-6. PubMed ID: 25465947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Quasi-SMILES and Monte Carlo Optimization to Develop Quantitative Feature Property/Activity Relationships (QFPR/QFAR) for Nanomaterials.
    Toropov AA; Rallo R; Toropova AP
    Curr Top Med Chem; 2015; 15(18):1837-44. PubMed ID: 25961527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of retention characteristics of heterocyclic compounds.
    Nesměrák K; Toropov AA; Toropova AP; Yildiz I; Yalcin I; Brozikova M; Klimešová V; Waisser K
    Anal Bioanal Chem; 2015 Dec; 407(30):9185-9. PubMed ID: 26427498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.